Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018

Elemer Piros Maintained (ARWR) at Buy with Increased Target to $165 on, Dec 17th, 2018

Elemer Piros of Cantor Fitzgerald, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy with Increased Target from $145 to $165 on, Dec 17th, 2018.

Elemer has made no other calls on ARWR in the last 4 months.



There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 0 agree with Elemer's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Elemer


  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $25 on, Thursday, September 6th, 2018
  • Madhu Kumar of "B. Riley Securities" Upgraded from Hold to Strong Buy on, Thursday, September 6th, 2018